Lab-grown meat is approved for consumption in the USA for the first time – this openness to new technologies is also needed in Eu
Laboratory meat could revolutionise nutrition. But in Europe it is partly banned as a precaution. Yet new technologies are indispensable if the world's population is to be fed without destroying the environment, writes Matthias Benz in the NZZ.
Monday, July 3, 2023
This commentary by Matthias Benz was first published in the "Neue Zürcher Zeitung" on 22 June 2023 under the title "Lab meat is approved for consumption in the USA for the first time - this openness to new technologies is also needed in Europe".
It may be a day for the history books: for the first time, lab-grown meat has been approved for sale to consumers in the USA. The companies Upside Foods and Good Meat are now allowed to sell chicken meat that does not come from killed chickens but is bred in the laboratory with the help of cell cultures.
This opens up a huge market for cultured meat. Until now, only the small country of Singapore had granted approval.
Better for animals and the environment
Enthusiasts promise themselves nothing less than a revolution in nutrition from lab meat. People can continue to eat real meat without animals having to die for it.
Hopes are also high for the environment. Conventional meat production involves an enormous consumption of resources and accounts for a large part of the ecological footprint of our food consumption.
Laboratory meat, on the other hand, does not require huge areas of land for animals and feed cultivation. It does not lead to over-fertilisation of landscapes and water bodies. It also promises to do better on the climate balance - although this point is still controversial because the bioreactors used consume a lot of energy.
Consumer scepticism
As great as the promises are, however, the doubts are also great. Frankly, no one can say today whether lab-grown meat will prevail.
The road to the mass market is long. Upside Foods and Good Meat are planning a quiet start: they will first launch their chicken products in two restaurants in San Francisco and Washington DC. According to industry experts, it may well be another five years before cultured meat can be found on American supermarket shelves.
It also remains to be seen how consumers will react to the new product. Lab-grown meat is still comparatively expensive, and it will probably take a while before it can compete with conventional meat in terms of price. Moreover, it could be met with fundamental scepticism. This was demonstrated a few months ago by the discussions in Italy, where opponents used the term "Frankenstein meat".
Ban in Italy
The decisive point is therefore not whether the future will actually belong to lab meat. What is central is how politics and society face such new technologies.
There are striking differences between America and Europe. In Italy, the Meloni government decided in March to ban the production of lab-grown meat in its own country. The Minister of Agriculture said that he was acting according to the precautionary principle. It has not been proven that the new product does not pose any risks. Other EU countries and Switzerland do not go that far. But here, too, it is clear that the approval procedures for "novel foods" are so strict that it will probably be years before lab-grown meat is on the European plate.
New technologies as the key
But the Europeans should take a leaf out of the Americans' book. Until now, Switzerland and the EU have turned a blind eye to the fact that conventional food production is a huge burden on the environment and the climate, out of consideration for the farmers.
New technologies are an important key to making food more environmentally friendly. Laboratory meat is just one of the many approaches. They also include green genetic engineering, which promises plant cultivation with fewer pesticides and less water consumption. Digitalised precision agriculture and indoor farming are also rich in opportunities.
Food production has become one of the most technologically interesting sectors in recent years. It is high time for Europe to make use of this potential.
Matthias Benz is a journalist at the "Neue Zürcher Zeitung".
Kindly note:
We, a non-native editorial team value clear and faultless communication. At times we have to prioritize speed over perfection, utilizing tools, that are still learning.
We are deepL sorry for any observed stylistic or spelling errors.
Related articles
Unwanted Invaders: Why Pesticides Are Essential in the Fight Against Invasive Species
They are small, highly mobile and extremely persistent: invasive species are spreading increasingly across Switzerland. Whether it is the Japanese beetle, the Asian hornet or newly discovered ant species, these unwelcome guests threaten not only native ecosystems, but also agriculture and residential areas. There is an urgent need for pesticides – including biocides and plant protection products – to combat these pests effectively.
Gene Drive Against Malaria: Blessing or Ecological Gamble?
Diseases such as malaria claim hundreds of thousands of lives every year. With so-called gene drive technology, scientists now have a tool that could theoretically eradicate the mosquitoes that spread these diseases. Yet the approach raises profound ethical and ecological questions.
The bottleneck of hunger: How the crisis in the Gulf is shaking global markets
While heating oil prices in Switzerland are on a rollercoaster, a far greater catastrophe is looming elsewhere. The blockage of the Strait of Hormuz is not only cutting off oil supplies, but also disrupting the global lifeline for fertilizers – with devastating consequences for global food security.
New genomic techniques in plants: what gene editing can do – and what it (still) cannot do
With CRISPR/Cas technology, genetic material can now be modified more precisely and efficiently than ever before. In plant breeding in particular, these “gene scissors” raise high hopes: crops that are resistant to diseases and pests, can withstand drought, and at the same time deliver higher yields. But how realistic are these expectations? What can genome editing actually achieve today – and what progress can we expect in the near future?